drugset
drugset / Trial / NCT01211821

Effect of BMS-914392 on Pharmacokinetics of Metoprolol

NCT01211821 ↗

Phase 1 Completed 18 enrolled Bristol-Myers Squibb PRA Health Sciences · collab
RandomizedCrossoverOpen-label

Summary

The purpose of the study is to assess the effects of BMS-914392 administration on the pharmacokinetics of a single-dose of metoprolol in healthy subjects.

Timeline

Start
2010-09
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-914392 Unknown 60 mg Oral
Subject Metoprolol Other / unclassified 200 mg Oral

Indications

atrial fibrillation